Cambridge Investment Research Advisors
ACHC icon

Cambridge Investment Research Advisors’s Acadia Healthcare ACHC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,089
Closed -$497K – 3811
2025
Q3 		$497K Buy
+20,089
New +$448K ﹤0.01% 2687

Other funds holding ACHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Cambridge Investment Research Advisors's ACHC Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 20,089 shares — an estimated $497K sold.

Cambridge Investment Research Advisors first reported a position in ACHC in Q3 2025 and held it in 1 quarter. The position peaked at $497K in Q3 2025. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 20,089 Acadia Healthcare shares in Q4 2025, an estimated $497K.
  • Cambridge Investment Research Advisors first reported a position in Acadia Healthcare in Q3 2025 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Acadia Healthcare position peaked at $497K in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.